1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Sergio Traversa, PharmD, is affiliated with Relmada Therapeutics, Inc, Coral Gables, Florida. Traversa has published research focused on the safety and efficacy of esmethadone in patients with major depressive disorder, including long-term studies and phase 3 randomized controlled trials addressing inadequate response to standard antidepressants. The author has contributed to articles between 2024 and 2025 in Psychiatrist.com, collaborating frequently with Andrea Mattarei, Andrew J. Cutler, Charles E. Inturrisi, Charles W. Gorodetzky, and Clotilde Guidetti.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
